Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Smartphone-Based Readerless System Measures Blood Glucose for Early Detection of Prediabetes

By LabMedica International staff writers
Posted on 03 Apr 2023

Prediabetes is characterized by high blood sugar levels that may progress to type 2 diabetes. More...

Fortunately, this condition can be reversed with lifestyle changes such as a healthier diet and exercise, if detected early. However, many individuals with prediabetes are unaware of their condition, which puts them at greater risk of developing diabetes and complications such as heart disease, kidney failure, and vision loss. Screening for prediabetes typically involves laboratory testing at a healthcare facility or using a portable glucometer for at-home testing. Unfortunately, access and cost may limit widespread screening. Now, researchers have discovered an optimal approach to enhance early detection of prediabetes.

Researchers at the University of Washington (Seattle, WA, USA) have developed GlucoScreen, which takes advantage of the capacitive touch sensing abilities of smartphones to measure blood glucose levels without the need for a separate reader. This approach will help reduce the cost and increase accessibility of glucose testing, particularly for large-scale one-time screenings. GlucoScreen test strips measure the electrochemical reaction created by mixing blood and enzymes as an amplitude along a curve at a rate of five times per second. The strip then transmits this curve data to the phone encoded as a series of touches at variable speeds using pulse width modulation. “Pulse width” refers to the distance between peaks in the signal - in this case, the length between taps. Each pulse width represents a value on the curve, with a greater distance between taps indicating a higher amplitude of the electrochemical reaction on the strip.

The new GlucoScreen system has several advantages over traditional glucose testing methods. By leveraging the capacitive touch sensing capabilities of smartphones, it eliminates the need for a separate reader, making glucose testing more accessible and cost-effective for one-time screening of a large population. Additionally, the system does not require complicated electronic components, reducing the cost of manufacturing and power consumption compared to conventional communication methods like Bluetooth and Wi-Fi. The test strip is designed with photodiodes, which draw power from the phone's flash, eliminating the need for batteries or a USB connection. The GlucoScreen app walks users through the testing process, and after the data is transmitted from the strip to the phone, the app uses machine learning to analyze the data and calculate a blood glucose reading.

The researchers conducted both in vitro and clinical testing to evaluate their approach. In the clinical study, they enrolled 75 consenting patients who were scheduled to undergo a laboratory blood glucose test. The performance of GlucoScreen was compared against that of a conventional strip and glucometer, with the laboratory test serving as the ground truth. While additional testing is required, the preliminary results suggest that GlucoScreen's accuracy is comparable to that of a glucometer. Of significance, the system was found to be accurate at the critical threshold between a normal blood glucose level of 99 mg/dL or below and prediabetes, which is defined as a blood glucose level between 100 and 125 mg/dL. The researchers believe that GlucoScreen's performance will improve with further inputs.

“In conventional screening, a person applies a drop of blood to a test strip, where the blood reacts chemically with the enzymes on the strip. A glucometer is used to analyze that reaction and deliver a blood glucose reading,” explained lead author Anandghan Waghmare, a Ph.D. student in the Allen School’s UbiComp Lab. “We took the same test strip and added inexpensive circuitry that communicates data generated by that reaction to any smartphone through simulated tapping on the screen. GlucoScreen then processes the data and displays the result right on the phone, alerting the person if they are at risk so they know to follow up with their physician.”

“Because we use the built-in capacitive touch screen that’s present in every smartphone, our solution can be easily adapted for widespread use. Additionally, our approach does not require low-level access to the capacitive touch data, so you don’t have to access the operating system to make GlucoScreen work.” explained co-author Jason Hoffman, a Ph.D. student in the Allen School. “We’ve designed it to be ‘plug and play.’ You don’t need to root the phone — in fact, you don’t need to do anything with the phone, other than install the app. Whatever model you have, it will work off the shelf.”

“One of the barriers I see in my clinical practice is that many patients can’t afford to test themselves, as glucometers and their test strips are too expensive. And, it’s usually the people who most need their glucose tested who face the biggest barriers,” said Thompson, a family physician and professor in the UW Department of Family Medicine and Department of Global Health. “Given how many of my patients use smartphones now, a system like GlucoScreen could really transform our ability to screen and monitor people with prediabetes and even diabetes.”

Related Links:
University of Washington


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Portable POCT Blood Gas Analyzer
BD100
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Illustration of CNF-sheet-mediated membrane fusion between an extracellular vesicle and a lipid nanoparticle carrying molecular beacons for internal microRNA detection. (Image Credit: Kawaguchi et al., Cell Reports Physical Science, 2026. DOI: 10.1016/j.xcrp.2026.103613)

Single-Vesicle Analysis Reveals Tissue-Associated Inflammatory Signatures

Chronic inflammation can persist for months or years when immune cells continue attacking tissues despite the absence of an active threat. It is associated with cancers, brain disorders, autoimmune diseases,... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Comprehensive Tumor Profiling Uncovers Overlooked Hereditary Cancer Risk Genes

Patients with solid tumors often undergo molecular profiling to identify alterations that can guide therapy. This testing may also reveal constitutional cancer-predisposing DNA variants, which are present... Read more

Hematology

view channel
Image: These new ANC reference ranges can help clinicians more accurately interpret neutrophil counts, reduce unnecessary testing and treatment interruptions, and help support more equitable care. (Photo courtesy of the American Society of Hematology)

New Reference Ranges Clarify Normal Neutrophil Counts in Duffy-Null Patients

Duffy-null status is a common genetic trait associated with naturally lower circulating white blood cell counts. It affects about 10% of the U.S. population and more than 66% of people with African or... Read more

Immunology

view channel
Image: Study design and collection of lower respiratory tract lining fluid (RTLF) using the PExA instrument. (Aguilera K, Hober A, Greilert Norin N, et al. eBioMedicine, 2026. doi:10.1016/j.ebiom.2026.106538)

Exhaled Breath Particles Reveal Virus-Specific Antibodies in the Lower Airways

Respiratory viruses such as influenza virus, SARS-CoV-2, and respiratory syncytial virus (RSV) require immune protection across the airway mucosa. Antibodies in the respiratory tract lining are important... Read more

Microbiology

view channel
Image: Four-quadrant streaking of fecal samples on chromogenic UTI agar shows various patterns of relative bacterial species abundance. The assorted shapes of the pinkish colonies indicate different E. coli strains. (Photo courtesy of Sokurenko Lab)

Stool Testing Predicts UTI Risk and Guides Antibiotic Selection

Urinary tract infections (UTIs) are a common reason for antibiotic prescribing in general medical practice and can be painful in postmenopausal women, sometimes progressing to kidney infection or life-threatening... Read more

Pathology

view channel
AI: Artificial intelligence; CNN: Convolutional neural networks; ResNet: Residual neural network. (Xing-hua Gao from The First Hospital of China Medical University, China Image Source Link: https://www.ovid.com/jnls/cmj/fulltext/10.1097/cm9.0000000000004154~deep-learning-based-computational-pathology-technologies)

Review Highlights Progress and Validation Needs for AI in Digital Pathology

Pathology remains the gold standard for disease diagnosis, but clinical laboratories face growing demands for faster, more reproducible diagnostic and prognostic workflows. Digital pathology based on whole-slide... Read more

Industry

view channel
Image: Siemens Healthineers has begun carving out its in vitro diagnostics business as a standalone company named Olyrian Diagnostics (Photo courtesy of Siemens Healthineers)

Siemens Healthineers Begins Transition Toward Standalone Olyrian Diagnostics Business

Siemens Healthineers has begun carving out its in vitro diagnostics business, which will operate as Olyrian Diagnostics. The new name will be introduced in stages as the business prepares to become a standalone... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.